Crossref
Hormone Receptor Positive Early Breast Cancer: What Role for Aromatase Inhibitors?
Clinical Medicine Reviews in Oncology · 2010
DOI: 10.4137/cmro.s4203 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Medicine Reviews in Oncology, 2010. Verfasst von Alice Dewdney and Sarah Needleman.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Needleman, A. D. A. S. (2010). Hormone Receptor Positive Early Breast Cancer: What Role for Aromatase Inhibitors?. Clinical Medicine Reviews in Oncology. https://doi.org/10.4137/cmro.s4203
Vancouver
Needleman ADAS. Hormone Receptor Positive Early Breast Cancer: What Role for Aromatase Inhibitors?. Clinical Medicine Reviews in Oncology. 2010. doi:10.4137/cmro.s4203
BibTeX
@article{Needleman2010,
author = {Needleman, Alice Dewdney and Sarah},
title = {Hormone Receptor Positive Early Breast Cancer: What Role for Aromatase Inhibitors?},
journal = {Clinical Medicine Reviews in Oncology},
year = {2010},
doi = {10.4137/cmro.s4203}
}
EUVIMED